openPR Logo
Press release

mRNA Vaccines and Therapeutics Market is projected to reach USD 253.83 billion by 2034, growing at a CAGR of 16.7%

12-26-2024 10:19 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

mRNA Vaccines and Therapeutics Market

mRNA Vaccines and Therapeutics Market

๐ฆ๐‘๐๐€ ๐•๐š๐œ๐œ๐ข๐ง๐ž๐ฌ ๐š๐ง๐ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐’๐ข๐ณ๐ž ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ, ๐š๐ง๐ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐“๐ก๐ž ๐ฆ๐‘๐๐€ ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž๐ฌ ๐š๐ง๐ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฐ๐จ๐ซ๐ญ๐ก ๐”๐’๐ƒ ๐Ÿ“๐Ÿ’.๐Ÿ‘๐Ÿ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐ž๐๐ข๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ž๐ฑ๐ฉ๐š๐ง๐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ๐Ÿ“๐Ÿ‘.๐Ÿ–๐Ÿ‘ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ’, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ๐Ÿ”.๐Ÿ•% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ’.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž:
This comprehensive study provides an accurate overview of the worldwide mRNA vaccines and therapeutics market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by type, application, treatment type, end user, and region in the study, which offers a comprehensive picture of the state of the market.

๐†๐ž๐ญ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/mrna-vaccines-and-therapeutics-market/request-for-sample

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
mRNA vaccines and therapies are medical interventions that utilize messenger RNA (mRNA) to direct the body's cells to create particular proteins that elicit an immune response or address health conditions. In vaccines like those for COVID-19, mRNA carries instructions for a protein present in the virus, stimulating the immune system to identify and combat the pathogen. Additionally, mRNA therapeutics are under investigation to address several conditions, such as cancer and genetic disorders, by guiding cells to generate therapeutic proteins or amend defective ones.

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐“๐ซ๐ž๐ง๐๐ฌ:
โ— Research and development (R&D), partnerships, and collaborations between key companies and research institutes are driving the innovation and creation of new mRNA vaccines by combining resources, expertise, and technologies to tackle scientific and production challenges.
โ— The rise in regulatory authorizations for mRNA-based products is fueling the growth of the global mRNA vaccines and therapeutics market.

๐“๐จ๐ฉ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ:
Because there are so many companies in the market, it is expected to be both competitive and fragmented. Here are the top companies in the market:

โ€ข Ethris
โ€ข Sanofi
โ€ข Arcturus Therapeutics
โ€ข Innovac Therapeutics
โ€ข Kernal Biologics
โ€ข Pantherna Therapeutics
โ€ข pHion Therapeutics
โ€ข Recode Therapeutics
โ€ข Rejuvenation Technologies
โ€ข RNAimmune
โ€ข Strand Therapeutics
โ€ข Walvax

๐ฆ๐‘๐๐€ ๐•๐š๐œ๐œ๐ข๐ง๐ž๐ฌ ๐š๐ง๐ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โ€ข In terms of application, the cancer segment is expected to grow at a rapid pace during the forecast period owing to the ability of mRNA technology to revolutionize cancer treatment by enabling the development of personalized cancer vaccines and cancer immunotherapies.
โ€ข Based on type, the conventional non-amplifying mRNA-based vaccines segment dominated the mRNA vaccines and therapeutics market share in 2024 owing to their proven efficacy and widespread adoption during the COVID-19 outbreak.
โ€ข In the global market, North America held the largest revenue share in 2024 due to robust healthcare infrastructure, significant investments in research and development, and rapid advancements in mRNA technology.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:

By Type Outlook (Revenue, USD Billion, 2020-2034)
โ€ข Self-Amplifying mRNA-Based Vaccines
โ€ข Conventional Non-Amplifying mRNA-Based Vaccines

By Application Outlook (Revenue, USD Billion, 2020-2034)
โ€ข Cancer
โ€ข Infectious Diseases
โ€ข Autoimmune Diseases
โ€ข Others

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)
โ€ข Monoclonal Antibody
โ€ข Gene Therapy
โ€ข Cell Therapy
โ€ข Other

By End User Outlook (Revenue, USD Billion, 2020-2034)
โ€ข Research Laboratories and Organizations
โ€ข Hospitals
โ€ข Clinics
โ€ข Others

๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐–๐ข๐ฌ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional analysis, in 2024, North America had the largest market share. The region's robust healthcare infrastructure, coupled with significant investments in research and development, has facilitated rapid advancements in mRNA technology.

Also, Asia Pacific is anticipated to register a substantial CAGR during the projection period due to the growing investment in biotechnology, expanding clinical trials, and increasing rates of infectious and chronic illnesses.

โ€ข North America (U.S., Canada)
โ€ข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โ€ข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โ€ข Latin America (Brazil, Mexico, Argentina)
โ€ข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:
Clinical Trial Biorepository & Archiving Solutions Market
https://www.polarismarketresearch.com/industry-analysis/clinical-trial-biorepository-and-archiving-solutions-market

Plasma Protease C1-inhibitor Market
https://www.polarismarketresearch.com/industry-analysis/plasma-protease-c1-inhibitor-market

Dental Equipment Market
https://www.polarismarketresearch.com/industry-analysis/dental-equipment-market

Equine Healthcare Market
https://www.polarismarketresearch.com/industry-analysis/equine-healthcare-market

Immunoassay Market
https://www.polarismarketresearch.com/industry-analysis/immunoassay-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

๐€๐›๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก & ๐‚๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐ˆ๐ง๐œ:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mRNA Vaccines and Therapeutics Market is projected to reach USD 253.83 billion by 2034, growing at a CAGR of 16.7% here

News-ID: 3797875 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expanding at a strong CAGR of 19.88% during the forecast period from 2026 to 2034.
Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expan โ€ฆ
The global mobile biometrics market is projected to be valued at approximately USD 53.10 billion in 2025 and is expected to witness strong growth through 2034, driven by rising concerns over data security, increasing smartphone-based digital transactions, and the growing adoption of biometric authentication across banking, enterprise, and government sectors. The market is anticipated to expand at a CAGR of 19.88% during the forecast period, reaching an estimated value ofโ€ฆ
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During 2026-2034 | AbbVie Inc., Croma-Pharma GmbH, Hugel, Inc.
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During โ€ฆ
Polaris Market Research recently introduced the latest update on Bioregenerative Aesthetic Injectables Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Bioregenerative Aesthetic Injectables Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of theโ€ฆ
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a 2.29% CAGR from 2026 to 2034
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a โ€ฆ
Global Copper Mining Market is currently valued at USD 191.96 Billion in 2025 and is anticipated to generate an estimated revenue of USD 235.28 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.29% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titled Copperโ€ฆ
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, Expanding at a 4.9% CAGR from 2026 to 2034
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, โ€ฆ
Global Specialty Oilfield Chemicals Market is currently valued at USD 11.0 Billion in 2025 and is anticipated to generate an estimated revenue of USD 16.7 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titledโ€ฆ

All 5 Releases


More Releases for RNA

Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs โ€ฆ
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current marketโ€ฆ
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA โ€ฆ
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, andโ€ฆ
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca โ€ฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,โ€ฆ
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca โ€ฆ
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - โ€ข 70% efforts of Primary Research โ€ข 15% efforts of Secondary Research โ€ข 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limitedโ€ฆ
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin โ€ฆ
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? โ€ข The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. โ€ข Expected exponentialโ€ฆ
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe โ€ฆ
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers aโ€ฆ